[Source: a GenomeWeb staff reporter ] – German drug developer Sygnis Pharma has bought Amnestix, a spin-out from the Translational Genomics Research Institute, for
Sygnis Pharma Buys TGen Spin-out Amnestix for $6.3M
June 9, 2008
Improving the quality of life in Arizona to benefit future generations.
June 9, 2008
[Source: a GenomeWeb staff reporter ] – German drug developer Sygnis Pharma has bought Amnestix, a spin-out from the Translational Genomics Research Institute, for